Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

17.8K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of hydrodynamic, mechanical, and interfacial stress during downstream processing on adeno-associated virus serotype 8 and 9.

Journal of pharmaceutical sciences·2025
Same author

Kinetic Modeling of the Antibody Disulfide Bond Reduction Reaction With Integrated Prediction of the Drug Load Profile for Cysteine-Conjugated ADCs.

Biotechnology and bioengineering·2024
Same author

Kinetic models towards an enhanced understanding of diverse ADC conjugation reactions.

Frontiers in bioengineering and biotechnology·2024
Same author

HIV ribonuclease H: continuing the search for small molecule antagonists.

HIV therapy·2024
Same author

Rational downstream development for adeno-associated virus full/empty capsid separation - A streamlined methodology based on high-throughput screening and mechanistic modeling.

Journal of chromatography. A·2024
Same author

From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis.

Free neuropathology·2023

Related Experiment Video

Updated: Feb 13, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K

Hexosaminidase assays.

Michaela Wendeler1, Konrad Sandhoff

  • 1LIMES, Membrane Biology and Lipid Biochemistry Unit, c/o Kekulé-Institut für Organische Chemie und Biochemie der Universität Bonn, Gerhard-Domagk-Str. 1, 53121 Bonn, Germany.

Glycoconjugate Journal
|May 14, 2008
PubMed
Summary

Beta-hexosaminidases are crucial lysosomal enzymes. This review details convenient assay methods for diagnosing GM2 gangliosidoses, studying enzyme function, and screening for inhibitors.

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Beta-hexosaminidases (EC 3.2.1.52) are lysosomal enzymes critical for glycoconjugate metabolism.
  • Deficiency in beta-hexosaminidases causes GM2 gangliosidoses, a group of lysosomal storage disorders.
  • Altered hexosaminidase levels are increasingly linked to inflammatory conditions.

Purpose of the Study:

  • To review convenient assay procedures for beta-hexosaminidases.
  • To cover applications including diagnostics, research, and inhibitor screening.
  • To provide an overview of established and novel assay techniques.

Main Methods:

  • Utilizing fluorogenic or chromogenic artificial substrates.
  • Employing the physiological glycolipid substrate GM2.

More Related Videos

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

12.9K
A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
17:35

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent

Published on: November 1, 2013

40.6K

Related Experiment Videos

Last Updated: Feb 13, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K
Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays
11:31

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Published on: July 4, 2018

12.9K
A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
17:35

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent

Published on: November 1, 2013

40.6K
  • Discussing alternative and high-throughput screening techniques.
  • Main Results:

    • Established assay systems are vital for diagnosing GM2 gangliosidoses and carrier screening.
    • In vitro assays are essential for characterizing knockout mice and enzyme variants.
    • Novel methods facilitate high-throughput screening for enzyme inhibitors.

    Conclusions:

    • Convenient and reliable beta-hexosaminidase assays are indispensable for clinical diagnostics and fundamental research.
    • These assays support the investigation of lysosomal storage disorders and enzyme mechanisms.
    • Recent advancements enable efficient screening for potential therapeutic inhibitors.